Annual Total Liabilities
$44.33 M
+$6.52 M+17.25%
December 31, 2024
Summary
- As of March 12, 2025, KROS annual total liabilities is $44.33 million, with the most recent change of +$6.52 million (+17.25%) on December 31, 2024.
- During the last 3 years, KROS annual total liabilities has risen by +$32.26 million (+267.09%).
- KROS annual total liabilities is now at all-time high.
Performance
KROS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$44.33 M
-$2.10 M-4.53%
December 31, 2024
Summary
- As of March 12, 2025, KROS quarterly total liabilities is $44.33 million, with the most recent change of -$2.10 million (-4.53%) on December 31, 2024.
- Over the past year, KROS quarterly total liabilities has stayed the same.
- KROS quarterly total liabilities is now -4.53% below its all-time high of $46.44 million, reached on September 30, 2024.
Performance
KROS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
KROS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.3% | 0.0% |
| 3 y3 years | +267.1% | +267.1% |
| 5 y5 years | +323.8% | +323.8% |
KROS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +267.1% | -4.5% | +284.7% |
| 5 y | 5-year | at high | +474.1% | -4.5% | +492.1% |
| alltime | all time | at high | +474.1% | -4.5% | +492.1% |
Keros Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $44.33 M(+17.2%) | $44.33 M(-4.5%) |
| Sep 2024 | - | $46.44 M(+36.2%) |
| Jun 2024 | - | $34.11 M(+7.0%) |
| Mar 2024 | - | $31.87 M(-15.7%) |
| Dec 2023 | $37.81 M(+28.8%) | $37.81 M(+24.4%) |
| Sep 2023 | - | $30.41 M(+1.2%) |
| Jun 2023 | - | $30.05 M(+2.0%) |
| Mar 2023 | - | $29.45 M(+0.3%) |
| Dec 2022 | $29.36 M | $29.36 M(+154.7%) |
| Sep 2022 | - | $11.53 M(-25.4%) |
| Jun 2022 | - | $15.45 M(+32.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $11.65 M(-3.6%) |
| Dec 2021 | $12.08 M(+56.4%) | $12.08 M(+5.2%) |
| Sep 2021 | - | $11.48 M(+47.1%) |
| Jun 2021 | - | $7.80 M(-16.6%) |
| Mar 2021 | - | $9.36 M(+21.2%) |
| Dec 2020 | $7.72 M(-26.2%) | $7.72 M(+3.1%) |
| Sep 2020 | - | $7.49 M(-17.5%) |
| Jun 2020 | - | $9.08 M(-6.8%) |
| Mar 2020 | - | $9.74 M(-6.9%) |
| Dec 2019 | $10.46 M(-28.6%) | $10.46 M |
| Dec 2018 | $14.65 M | - |
FAQ
- What is Keros Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Keros Therapeutics?
- What is Keros Therapeutics annual total liabilities year-on-year change?
- What is Keros Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Keros Therapeutics?
- What is Keros Therapeutics quarterly total liabilities year-on-year change?
What is Keros Therapeutics annual total liabilities?
The current annual total liabilities of KROS is $44.33 M
What is the all time high annual total liabilities for Keros Therapeutics?
Keros Therapeutics all-time high annual total liabilities is $44.33 M
What is Keros Therapeutics annual total liabilities year-on-year change?
Over the past year, KROS annual total liabilities has changed by +$6.52 M (+17.25%)
What is Keros Therapeutics quarterly total liabilities?
The current quarterly total liabilities of KROS is $44.33 M
What is the all time high quarterly total liabilities for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total liabilities is $46.44 M
What is Keros Therapeutics quarterly total liabilities year-on-year change?
Over the past year, KROS quarterly total liabilities has changed by $0.00 (0.00%)